@ FierceBiotech

Related by string. * : email dg.prospectus requests @ baml.com . @ STEIN LINE HQ RT @ . avid tweeter @ Lunchboxbunch . tf.TFN Europe newsdesk @ thomson.com . #,# @ [001] . TFN.newsdesk @ thomson.com ami . tf.TFN Europe newsdesk @ thomsonreuters.com . philip.waller @ thomson.com paw . Folding @ Home . Notes @ Plate umpire / : FierceBiotech * Follow @ FierceBiotech *

Related by context. Frequent words. (Click for all words.) 60 Drugmaker 55 Biotechs 50 Alizyme 50 CORRECTED UPDATE 49 CORRECTED 49 Premarket Movers 49 REFILE 49 Astrazeneca 48 DEALTALK 48 REFILE UPDATE 48 Drug Makers 48 STOCKS NEWS US 48 Summary Box 48 Genzyme GENZ 48 Pfizer Wyeth 47 pharma 47 CORRECTED CORRECTED 47 Celgene CELG 47 Gilead Sciences GILD 47 Biotech 47 Big Pharma 47 biotech 47 Novartis NVS 46 Array BioPharma 46 RPT UPDATE 46 pharmas 46 Merck MRK 46 Pfizer PFE 46 Schering Plough SGP 45 Idenix Pharmaceuticals 45 Onyx Pharmaceuticals 45 Novartis 45 B'lore 45 GlaxoSmithkline 45 Pfizer 45 Biogen Idec BIIB 45 Pharma 45 Roche Genentech 44 Abbott Labs 44 Glenmark Pharma 44 Shares Soar 44 NEWS SAN DIEGO 44 Sanofi Aventis 44 BIOTECH 44 Bristol Myers Squibb BMY 44 AstraZeneca AZN 44 KTRV Fox 44 PHARMACEUTICALS 44 BRIEF 44 Novartis NYSE NVS 44 UDPATE 44 Eli Lilly LLY 44 Amgen Nasdaq AMGN 43 PDL BioPharma 43 biotechs 43 Halozyme Therapeutics 43 Osiris Therapeutics 43 Optimer Pharmaceuticals 43 Sangamo BioSciences 43 Genetech 43 Pfizer NYSE PFE 43 INTERVIEW UPDATE 1 43 Bayer Schering 43 Glance STOCKS NEWS EUROPE 43 GTC Biotherapeutics 43 Amgen AMGN 43 Human Genome Sciences HGSI 43 ONXX 43 Xoma 43 biopharma 43 Antigenics 42 Ark Therapeutics 42 Avanir 42 GlaxoSmithKline 42 AstraZeneca 42 UPDATE 42 U.S 42 Movers roundup 42 GSK 42 Biogen 42 GlaxoSmithKline PLC GSK 42 PHARMA 42 Cell Therapeutics 42 Analyst downgrades 41 SPECIAL REPORT 41 LLY 41 Auxilium Pharmaceuticals 41 bio pharma 41 Eli Lilly NYSE LLY 41 NEWSMAKER 41 Encysive Pharmaceuticals 41 Glaxo 41 Genzyme 41 Shares Surge 41 TOPWRAP 41 Natco Pharma 41 Premarket roundup 41 Immunogen 41 MARKET REPORT 41 Gets Approval 41 pharmaceutical

Back to home page